Wenxuan Xie

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0009-0009-5024-7451

发表论文 96 篇 · 总被引 718 次 · h-index 13

代表论文

• Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer (2025 · JAMA Oncology · 被引 13)
• Conversion Therapy Based on TACE/HAIC-Based Treatment to Improve the Therapeutic Effect of Initially Unresectable Hepatocellular Carcinoma (2025 · Liver Cancer · 被引 6)
• Neoadjuvant immune-checkpoint blockade therapy in combination with TACE for resectable hepatocellular carcinoma with high recurrence risk: A phase II, single-arm clinical trial (MORNING). (2025 · Journal of Clinical Oncology · 被引 1)
• [Clinical efficacy observation of heat-sensitive moxibustion combined with intrapleural perfusion of cisplatin in treatment of malignant pleural effusion]. (2024 · PubMed · 被引 1)
• Neoadjuvant immune-checkpoint blockade therapy combined with TACE for resectable hepatocellular carcinoma with high recurrence risk: A phase II, single-arm clinical trial (MORNING). (2024 · Journal of Clinical Oncology · 被引 1)
• Molecular classification identifies aggressive gastrointestinal stromal tumor subtype targetable by PARP inhibitors (2026 · Cellular Oncology)